WST · West Pharmaceutical Services Inc · Proposed Sales
$418.76
+2.34 (+0.56%)
At close · Nov 16
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$29.01B
Shares
69.66M
Volume · Nov 16
84.42K
Avg daily vol (3M)
601.93K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2026-05-07 | Hofmann Thomas W | Director | 3,384 | 2026-05-07 | Fidelity Brokerage Services LLC |
| 2024-08-06 | Green Eric Mark | Officer, Director | 30,732 | 2024-08-06 | Fidelity Brokerage Services LLC |
| 2024-05-10 | Hofmann Thomas W | Director | 617 | 2024-05-10 | Fidelity Brokerage Services LLC |
| 2024-05-07 | Green Eric Mark | Officer, Director | 66,000 | 2024-05-07 | Fidelity Brokerage Services LLC |
| 2024-02-27 | Green Eric Mark | Officer, Director | 64,132 | 2024-02-27 | Fidelity Brokerage Services LLC |
| 2023-08-08 | ERIC GREEN | Officer, Director | 44,000 | 2023-08-08 | Morgan Stanley Smith Barney LLC |
| 2023-05-09 | ERIC GREEN | Officer, Director | 44,000 | 2023-05-09 | Morgan Stanley Smith Barney LLC |
| 2023-05-01 | THOMAS HOFMANN | Director | 1,212 | 2023-05-01 | Morgan Stanley Smith Barney LLC |
Showing 1–8 of 8 filings
Key facts
CIK
105770
CUSIP
955306105
13F (30d)
681 filings
624 filers
Visit website
Investor relations